Skip to content

Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01094743
Enrollment
52
Registered
2010-03-29
Start date
2010-02-01
Completion date
2010-03-01
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study is to compare visual acuity and redness of eyes between a prototype contact lens and an already marketed contact lens.

Interventions

Silicone hydrogel contact lens

DEVICElotrafilcon B lens

Silicon Hydrogel contact lens

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. The subject must be at least 18 years of age and no more than 39 years of age. 2. The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of DW for a minimum of 1 month prior to the study) and willing to wear the study lenses on a daily wear basis (defined as a minimum of 6 hours of wear per day at least five days of the week) for the duration of the study. 3. The subject's optimal vertexed spherical equivalent distance correction must be between -1.00 and - 9.00D. 4. Any cylinder power must be ≤ -0.75D. 5. The subject must have visual acuity best correctable to 20/25+3 or better for each eye. 6. The subject must read and sign the Statement of Informed Consent. 7. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion criteria

1. Ocular or systemic allergies or disease which might interfere with contact lens wear. 2. Systemic disease or use of medication which might interfere with contact lens wear. 3. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear. 4. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear. 5. Any ocular infection. 6. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear. 7. Pregnancy or lactation. 8. Diabetes. 9. Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV). 10. Habitual contact lens type is toric, multifocal, or is worn as extended wear.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity Monocularafter 1 week of lens wearSnellen monocular visual acuity measurement
Visual Acuity Binocularafter 1 week of lens wearSnellen binocular visual acuity measurement
Subjective Assessment of Lens Comfortafter 1 week of lens wearContact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
Subjective Assessment of Quality of Visionafter 1 week of lens wearContact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Secondary

MeasureTime frameDescription
Bulbar Rednessafter 1 week of lens wearScale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.
Subjective Assessment of Lens Comfort10 minutes after lens insertion at time of initial lens fittingContact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
Limbal Rednessafter 1 week of lens wearScale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.

Countries

United States

Participant flow

Participants by arm

ArmCount
Galyfilcon A Prototype Lens / Lotrafilcon B Lens
All enrolled subjects were to wear both lenses through the course of the study.
52
Total52

Withdrawals & dropouts

PeriodReasonFG000
Period 1Unsatisfactory comfort at lens fitting2

Baseline characteristics

CharacteristicGalyfilcon A Prototype Lens / Lotrafilcon B Lens
Age, Continuous28 years
STANDARD_DEVIATION 5.76
Region of Enrollment
United States
52 participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
35 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 52
serious
Total, serious adverse events
0 / 52

Outcome results

Primary

Subjective Assessment of Lens Comfort

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Time frame: after 1 week of lens wear

Population: Completed subjects

ArmMeasureValue (MEAN)Dispersion
Galyfilcon A PrototypeSubjective Assessment of Lens Comfort66.23 units on a scaleStandard Deviation 24.112
Lotrafilcon BSubjective Assessment of Lens Comfort55 units on a scaleStandard Deviation 21.844
Primary

Subjective Assessment of Quality of Vision

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Time frame: after 1 week of lens wear

ArmMeasureValue (MEAN)Dispersion
Galyfilcon A PrototypeSubjective Assessment of Quality of Vision63.22 units on a scaleStandard Deviation 25.345
Lotrafilcon BSubjective Assessment of Quality of Vision59.83 units on a scaleStandard Deviation 20.036
Primary

Visual Acuity Binocular

Snellen binocular visual acuity measurement

Time frame: after 1 week of lens wear

Population: All completed subjects

ArmMeasureGroupValue (NUMBER)
Galyfilcon A PrototypeVisual Acuity Binocular20/15 binocular40 participants
Galyfilcon A PrototypeVisual Acuity Binocular20/20 binocular10 participants
Lotrafilcon BVisual Acuity Binocular20/15 binocular42 participants
Lotrafilcon BVisual Acuity Binocular20/20 binocular8 participants
Primary

Visual Acuity Monocular

Snellen monocular visual acuity measurement

Time frame: after 1 week of lens wear

Population: All completed subjects

ArmMeasureGroupValue (NUMBER)
Galyfilcon A PrototypeVisual Acuity Monocular20/15 monocular59 eyes
Galyfilcon A PrototypeVisual Acuity Monocular20/20 monocular40 eyes
Galyfilcon A PrototypeVisual Acuity Monocular20/25 monocular1 eyes
Galyfilcon A PrototypeVisual Acuity Monocular20/30 monocular0 eyes
Lotrafilcon BVisual Acuity Monocular20/30 monocular1 eyes
Lotrafilcon BVisual Acuity Monocular20/15 monocular64 eyes
Lotrafilcon BVisual Acuity Monocular20/25 monocular5 eyes
Lotrafilcon BVisual Acuity Monocular20/20 monocular30 eyes
Secondary

Bulbar Redness

Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.

Time frame: after 1 week of lens wear

ArmMeasureGroupValue (NUMBER)
Galyfilcon A PrototypeBulbar RednessGrade 0 None44 eyes
Galyfilcon A PrototypeBulbar RednessGrade 1 Trace50 eyes
Galyfilcon A PrototypeBulbar RednessGrade 2 Mild6 eyes
Lotrafilcon BBulbar RednessGrade 0 None34 eyes
Lotrafilcon BBulbar RednessGrade 1 Trace64 eyes
Lotrafilcon BBulbar RednessGrade 2 Mild2 eyes
Secondary

Limbal Redness

Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.

Time frame: after 1 week of lens wear

ArmMeasureGroupValue (NUMBER)
Galyfilcon A PrototypeLimbal RednessGrade 0 None37 eyes
Galyfilcon A PrototypeLimbal RednessGrade 1 Trace61 eyes
Galyfilcon A PrototypeLimbal RednessGrade 2 Mild2 eyes
Lotrafilcon BLimbal RednessGrade 0 None35 eyes
Lotrafilcon BLimbal RednessGrade 1 Trace61 eyes
Lotrafilcon BLimbal RednessGrade 2 Mild4 eyes
Secondary

Subjective Assessment of Lens Comfort

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Time frame: 10 minutes after lens insertion at time of initial lens fitting

ArmMeasureValue (MEAN)Dispersion
Galyfilcon A PrototypeSubjective Assessment of Lens Comfort76.67 units on a scaleStandard Deviation 18.487
Lotrafilcon BSubjective Assessment of Lens Comfort65 units on a scaleStandard Deviation 19.842

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026